178 related articles for article (PubMed ID: 32399935)
1. Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
Lai Y; He Z; Zhang A; Yan Z; Zhang X; Hu S; Wang N; He H
Genes Genomics; 2020 Jun; 42(6):691-698. PubMed ID: 32399935
[TBL] [Abstract][Full Text] [Related]
2. SAHA inhibits the transcription initiation of HPV18 E6/E7 genes in HeLa cervical cancer cells.
He H; Liu X; Wang D; Wang Y; Liu L; Zhou H; Luo X; Wang N; Ji B; Luo Y; Zhang T
Gene; 2014 Dec; 553(2):98-104. PubMed ID: 25300249
[TBL] [Abstract][Full Text] [Related]
3. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.
Chakraborty S; Das K; Saha S; Mazumdar M; Manna A; Chakraborty S; Mukherjee S; Khan P; Adhikary A; Mohanty S; Chattopadhyay S; Biswas SC; Sa G; Das T
J Biol Chem; 2014 Oct; 289(42):29074-85. PubMed ID: 25157104
[TBL] [Abstract][Full Text] [Related]
4. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
5. Brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes.
He H; Luo Y
Cell Cycle; 2012 Feb; 11(3):617-27. PubMed ID: 22262178
[TBL] [Abstract][Full Text] [Related]
6. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
7. SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter.
Smith JA; Haberstroh FS; White EA; Livingston DM; DeCaprio JA; Howley PM
Virology; 2014 Nov; 468-470():311-321. PubMed ID: 25222147
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
[TBL] [Abstract][Full Text] [Related]
9. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
Teissier S; Pang CL; Thierry F
Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
[TBL] [Abstract][Full Text] [Related]
10. Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.
Jha S; Vande Pol S; Banerjee NS; Dutta AB; Chow LT; Dutta A
Mol Cell; 2010 Jun; 38(5):700-11. PubMed ID: 20542002
[TBL] [Abstract][Full Text] [Related]
11. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
13. Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.
Villanueva R; Morales-Peza N; Castelán-Sánchez I; García-Villa E; Tapia R; Cid-Arregui A; García-Carrancá A; López-Bayghen E; Gariglio P
BMC Cancer; 2006 Aug; 6():218. PubMed ID: 16945153
[TBL] [Abstract][Full Text] [Related]
14. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.
Zhang L; Tian S; Pei M; Zhao M; Wang L; Jiang Y; Yang T; Zhao J; Song L; Yang X
Oncol Rep; 2019 Dec; 42(6):2655-2669. PubMed ID: 31661141
[TBL] [Abstract][Full Text] [Related]
16. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.
Baldwin A; Huh KW; Münger K
J Virol; 2006 Jul; 80(13):6669-77. PubMed ID: 16775354
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
Brant AC; Menezes AN; Felix SP; de Almeida LM; Sammeth M; Moreira MAM
Genomics; 2019 Dec; 111(6):1853-1861. PubMed ID: 30552977
[TBL] [Abstract][Full Text] [Related]
19. IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells.
Hao Y; Yan Z; Zhang A; Hu S; Wang N; Luo XG; Ma W; Zhang TC; He H
Virus Res; 2020 May; 281():197907. PubMed ID: 32113834
[TBL] [Abstract][Full Text] [Related]
20. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: a mechanistic study including molecular docking.
Saha SK; Khuda-Bukhsh AR
Eur J Pharmacol; 2014 Dec; 744():132-46. PubMed ID: 25448308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
